Pretax income is the income that a company earns before paying income taxes. Kala Bio's pretax income for the
three
months ended in Dec. 2023 was $-8.63 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-42.20 Mil.
Kala Bio's pretax margin was %.
During the past 9 years, Kala Bio's highest Pretax Margin was -1151.64%. The lowest was -37071.11%. And the median was -1553.29%.
Kala Bio Pre-Tax Income Historical Data
The historical data trend for Kala Bio's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kala Bio's Pre-Tax Income
For the Biotechnology subindustry, Kala Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kala Bio's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kala Bio's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Kala Bio's Pre-Tax Income falls into.
Kala Bio Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Kala Bio's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kala Bio (NAS:KALA) Pre-Tax Income Explanation
Kala Bio's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 9 years, Kala Bio's highest Pretax Margin was -1151.64%. The lowest was -37071.11%. And the median was -1553.29%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kala Bio Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Kala Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare and severe eye diseases. KALA's lead product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KALA has been successfully added to your 